Parthenolide relieves pain and promotes M2 microglia/macrophage polarization in rat model of neuropathy

Neural Plasticity

Volumn 2015, Issue , 2015, Pages

  Popiolek Barczyk, Katarzyna ^a   Kolosowska, Natalia ^a   Piotrowska, Anna ^a   Makuch, Wioletta ^a   Rojewska, Ewelina ^a   Jurga, Agnieszka M ^a   Pilat, Dominika ^a   Mika, Joanna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PARTHENOLIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; ANALGESIC AGENT; SESQUITERPENE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL POLARITY; CHRONIC CONSTRICTION INJURY; CONTROLLED STUDY; DOWN REGULATION; HYPERALGESIA; INTRACELLULAR SIGNALING; MACROPHAGE; MALE; MICROGLIA; NEUROPATHIC PAIN; NEUROPATHY; NONHUMAN; RAT; SCIATIC NERVE; ANIMAL; CELL CULTURE; CHRONIC DISEASE; DRUG EFFECTS; METABOLISM; NEURALGIA; SCIATIC NEUROPATHY; SIGNAL TRANSDUCTION; WISTAR RAT;

ANALGESICS; ANIMALS; CELL POLARITY; CELLS, CULTURED; CHRONIC DISEASE; HYPERALGESIA; MACROPHAGES; MALE; MICROGLIA; NEURALGIA; RATS; RATS, WISTAR; SCIATIC NEUROPATHY; SESQUITERPENES; SIGNAL TRANSDUCTION;

EID: 84930653327     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2015/676473     Document Type: Article

References (97)

1. R. Baron, "Mechanisms of disease: neuropathic pain - a clinical perspective," Nature Clinical Practice Neurology, vol. 2, no. 2, pp. 95-106, 2006.
2. A. Szczudlik, J. Dobrogowski, J. Wordliczek et al., "Diagnosis and management of neuropathic pain: review of literature and recommendations of the Polish Association for the Study of Pain and the PolishNeurological Society - part one," Neurologia i Neurochirurgia Polska, vol. 48, no. 4, pp. 262-271, 2014.
3. C. J. Woolf and R. J. Mannion, "Neuropathic pain: aetiology, symptoms, mechanisms, and management," The Lancet, vol. 353, no. 9168, pp. 1959-1964, 1999.
4. J. Mika, K. Popiolek-Barczyk, E. Rojewska et al., "Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain," PLoS ONE, vol. 9, no. 8,Article ID e104420, 2014.
5. J. Mika, M. Zychowska, K. Popiolek-Barczyk, E. Rojewska, and B. Przewlocka, "Importance of glial activation in neuropathic pain," European Journal of Pharmacology, vol. 716, no. 1-3, pp. 106-119, 2013.
6. J. Mika, M. Osikowicz, W. Makuch, and B. Przewlocka, "Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain," European Journal of Pharmacology, vol. 560, no. 2-3, pp. 142-149, 2007.
7. S. Taves, T. Berta, G. Chen, and R.-R. Ji, "Microglia and spinal cord synaptic plasticity in persistent pain," Neural Plasticity, vol. 2013, Article ID 753656, 10 pages, 2013.
8. M. Tsuda, T. Masuda, H. Tozaki-Saitoh, and K. Inoue, "Microglial regulation of neuropathic pain," Journal of Pharmacological Sciences, vol. 121, no. 2, pp. 89-94, 2013.
9. S. David and A. Kroner, "Repertoire of microglial and macrophage responses after spinal cord injury," Nature Reviews Neuroscience, vol. 12, no. 7, pp. 388-399, 2011.
10. J. M. Crain, M. Nikodemova, and J. J. Watters, "Microglia express distinctM1 andM2phenotypic markers in the postnatal and adult central nervous system in male and female mice," Journal of Neuroscience Research, vol. 91, no. 9, pp. 1143-1151, 2013.
11. K. A. Kigerl, J. C. Gensel, D. P. Ankeny, J. K. Alexander, D. J. Donnelly, and P. G. Popovich, "Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injuredmouse spinal cord," Journal of Neuroscience, vol. 29, no. 43, pp. 13435-13444, 2009.
12. N. N. Burke, D. M. Kerr, O. Moriarty, D. P. Finn, and M. Roche, "Minocycline modulates neuropathic pain behaviour and cortical M1-M2 microglial gene expression in a rat model of depression," Brain, Behavior, and Immunity, vol. 42, pp. 147-156, 2014.
13. X. Hu, P. Li, Y. Guo et al., "Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia," Stroke, vol. 43, no. 11, pp. 3063-3070, 2012.
14. K. Kobayashi, S. Imagama, T. Ohgomori et al., "Minocycline selectively inhibitsM1 polarization of microglia," Cell Death and Disease, vol. 4, no. 3, article e525, 2013.
15. B. Koscsó, B. Csóka, E. Kókai et al., "Adenosine augments IL- 10-induced STAT3 signaling in M2c macrophages," Journal of Leukocyte Biology, vol. 94, no. 6, pp. 1309-1315, 2013.
16. E. Rojewska, K. Popiolek-Barczyk, A. M. Jurga, W. Makuch, B. Przewlocka, and J. Mika, "Involvement of pro- and antinociceptive factors in minocycline analgesia in rat neuropathic pain model," Journal ofNeuroimmunology, vol. 277, no. 1-2,pp. 57-66, 2014.
17. J. Mika, M. Osikowicz, E. Rojewska et al., "Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain," European Journal of Pharmacology, vol. 623, no. 1-3, pp. 65-72, 2009.
18. M. Levin, "Herbal treatment of headache,"Headache, vol. 52,pp. 76-80, 2012.
19. P. Magni, M. Ruscica, E. Dozio, E. Rizzi, G. Beretta, and R. M. Facino, "Parthenolide inhibits the LPS-induced secretion of IL-6 and TNF-α and NF-κB nuclear translocation in BV-2 microglia," Phytotherapy Research, vol. 26, no. 9, pp. 1405-1409, 2012.
20. K. Popiolek-Barczyk, W. Makuch, E. Rojewska, D. Pilat, and J. Mika, "Inhibition of intracellular signaling pathways NF-κB and MEK1/2 attenuates neuropathic pain development and enhances morphine analgesia," Pharmacological Reports, vol. 66, no. 5, pp. 845-851, 2014.
21. P. M. Bork, M. L. Schmitz, M. Kuhnt, C. Escher, and M. Heinrich, "Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factorNF-κB," FEBS Letters, vol. 402, no. 1, pp. 85-90, 1997.
22. S. P. Hehner, M. Heinrich, P. M. Bork et al., "Sesquiterpene lactones specifically inhibit activation of NF-κB by preventing the degradation of IκB-α and IκB-β," Journal of Biological Chemistry, vol. 273, no. 3, pp. 1288-1297, 1998.
23. B.H. B. Kwok, B. Koh, M. I. Ndubuisi,M. Elofsson, and C.M. Crews, "The anti-inflammatory natural product parthenolide fromthemedicinal herb Feverfew directly binds to and inhibits IκB kinase," Chemistry&Biology, vol. 8, no.8,pp. 759-766, 2001.
24. R. Sobota, M. Szwed, A. Kasza, M. Bugno, and T. Kordula, "Parthenolide inhibits activation of signal transducers and activators of transcription (STATs) induced by cytokines of the IL-6 family," Biochemical and Biophysical Research Communications, vol. 267, no. 1, pp. 329-333, 2000.
25. B. L. Fiebich, K. Lieb, S. Engels, and M. Heinrich, "Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells," Journal of Neuroimmunology, vol. 132, no. 1-2, pp. 18-24, 2002.
26. H.Uchi, J.-F. Arrighi, J.-P.Aubry,M. Furue, and C.Hauser, "The sesquiterpene lactone parthenolide inhibits LPS- but not TNFalpha- induced maturation of human monocyte-derived dendritic cells by inhibition of the p38 mitogen-activated protein kinase pathway," Journal of Allergy and Clinical Immunology, vol. 110, no. 2, pp. 269-276, 2002.
27. E. Dominguez, C. Rivat, B. Pommier, A. Mauborgne, and M. J. Pohl, "JAK/STAT3 pathway is activated in spinal cordmicroglia after peripheral nerve injury and contributes to neuropathic pain development in rat," Journal of Neurochemistry, vol. 107, no. 1, pp. 50-60, 2008.
28. X.-S. Song, J.-L. Cao, Y.-B. Xu, J.-H. He, L.-C. Zhang, and Y.-M. Zeng, "Activation of ERK/CREB pathway in spinal cord contributes to chronic constrictive injury-induced neuropathic pain in rats," Acta Pharmacologica Sinica, vol. 26, no. 7, pp. 789-798, 2005.
29. N. R. Bhat, P. Zhang, J. C. Lee, and E. L. Hogan, "Extracellular signal-regulated kinase and p38 subgroups of mitogenactivated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-γ gene expression in endotoxin-stimulated primary glial cultures," The Journal of Neuroscience, vol. 18, no. 5, pp. 1633-1641, 1998.
30. S.-X. Jin, Z.-Y. Zhuang, C. J.Woolf, and R.-R. Ji, "P38 mitogenactivated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain," Journal of Neuroscience, vol. 23, no. 10, pp. 4017-4022, 2003.
31. W. Makuch, J. Mika, E. Rojewska, M. Zychowska, and B. Przewlocka, "Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin- 1-induced analgesia in acute and neuropathic pain in rats," Neuropharmacology, vol. 75, pp. 445-457, 2013.
32. M. Tsuda, A. Mizokoshi, Y. Shigemoto-Mogami, S. Koizumi, and K. Inoue, "Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury," Glia, vol. 45, no. 1, pp. 89-95, 2004.
33. M. Zimmermann, "Ethical guidelines for investigations of experimental pain in conscious animals," Pain, vol. 16, no. 2, pp. 109-110, 1983.
34. G. J. Bennett and Y.-K. Xie, "A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man," Pain, vol. 33, no. 1, pp. 87-107, 1988.
35. M. Osikowicz, J. Mika,W. Makuch, and B. Przewlocka, "Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain," Pain, vol. 139, no. 1, pp. 117-126, 2008.
36. S. J. R. Elmes, M. D. Jhaveri, D. Smart, D. A. Kendall, and V. Chapman, "Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain," European Journal of Neuroscience, vol. 20, no. 9, pp. 2311-2320, 2004.
37. T. L. Yaksh and T. A. Rudy, "Chronic catheterization of the spinal subarachnoid space," Physiology and Behavior, vol. 17, no. 6, pp. 1031-1036, 1976.
38. P. Chomczynski and N. Sacchi, "Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction," Analytical Biochemistry, vol. 162, no. 1, pp. 156-159, 1987.
39. K. Inoue, M. Tsuda, and H. Tozaki-Saitoh, "Modification of neuropathic pain sensation through microglial ATP receptors," Purinergic Signalling, vol. 3, no. 4, pp. 311-316, 2007.
40. J. Scholz and C. J.Woolf, "The neuropathic pain triad: neurons, immune cells and glia," Nature Neuroscience, vol. 10, no. 11, pp. 1361-1368, 2007.
41. R. Vallejo, D. M. Tilley, L. Vogel, and R. Benyamin, "The role of glia and the immune system in the development and maintenance of neuropathic pain," Pain Practice, vol. 10, no. 3, pp. 167-184, 2010.
42. E. Rojewska, M. Korostynski, R. Przewlocki, B. Przewlocka, and J. Mika, "Expression profiling of genes modulated by minocycline in a rat model of neuropathic pain," Molecular Pain, vol. 10, article 47, 2014.
43. A. Ledeboer, E. M. Sloane, E. D. Milligan et al., "Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation," Pain, vol. 115, no. 1-2, pp. 71-83, 2005.
44. Z. G. Piao, I.-H. Cho, C. K. Park et al., "Activation of glia and microglial p38 MAPK in medullary dorsal horn contributes to tactile hypersensitivity following trigeminal sensory nerve injury," Pain, vol. 121, no. 3, pp. 219-231, 2006.
45. V. Raghavendra, F. Tanga, and J. A. Deleo, "Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy," Journal of Pharmacology and Experimental Therapeutics, vol. 306, no. 2, pp. 624-630, 2003.
46. R. López-Vales,A. Redensek, T. A. A. Skinner et al., "Fenretinide promotes functional recovery and tissue protection after spinal cord contusion injury in mice," Journal of Neuroscience, vol. 30, no. 9, pp. 3220-3226, 2010.
47. Y. Nishio, M. Koda, M. Hashimoto et al., "Deletion of macrophage migration inhibitory factor attenuates neuronal death and promotes functional recovery after compressioninduced spinal cord injury in mice," Acta Neuropathologica, vol. 117, no. 3, pp. 321-328, 2009.
48. P. G. Popovich, Z.Guan, P.Wei, I.Huitinga,N. van Rooijen, and B. T. Stokes, "Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury," Experimental Neurology, vol. 158, no. 2, pp. 351-365, 1999.
49. A. Redensek, K. I. Rathore, J. L. Berard et al., "Expression and detrimental role of hematopoietic prostaglandin D synthase in spinal cord contusion injury," Glia, vol. 59, no. 4, pp. 603-614, 2011.
50. V. Chhor, T. Le Charpentier, S. Lebon et al., "Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro," Brain, Behavior, and Immunity, vol. 32, pp. 70-85, 2013.
51. K. Chatzipanteli, R. Garcia, A. E. Marcillo, K. E. Loor, S. Kraydieh, and W. D. Dietrich, "Temporal and segmental distribution of constitutive and inducible nitric oxide synthases after traumatic spinal cord injury: effect of aminoguanidine treatment," Journal of Neurotrauma, vol. 19, no. 5, pp. 639-651, 2002.
52. R. López-Vales, G. García-Alías, J. Forés, J. M. Vela,X.Navarro, and E. Verdú, "Transplanted olfactory ensheathing cells modulate the inflammatory response in the injured spinal cord," Neuron Glia Biology, vol. 1, pp. 201-209, 2004.
53. D. D. Pearse, K. Chatzipanteli, A. E. Marcillo, M. B. Bunge, and W. D. Dietrich, "Comparison of iNOS inhibition by antisense and pharmacological inhibitors after spinal cord injury," Journal of Neuropathology and Experimental Neurology, vol. 62, no. 11, pp. 1096-1107, 2003.
54. H. Possel, H. Noack, J. Putzke, G.Wolf, and H. Sies, "Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia: in vitro and in vivo studies," Glia, vol. 32, no. 1, pp. 51-59, 2000.
55. P. Przanowski, M. Dabrowski, A. Ellert-Miklaszewska et al., "The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia," Journal of Molecular Medicine, vol. 92, no. 3, pp. 239-254, 2014.
56. J. Mika, M. Korostynski, D. Kaminska et al., "Interleukin- 1alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain model," Pain, vol. 138, no. 3,pp. 587-597, 2008.
57. A. K. Clark, F. D'Aquisto, C. Gentry, F. Marchand, S. B. McMahon, and M. Malcangio, "Rapid co-release of interleukin 1 and caspase 1 in spinal cord inflammation," Journal of Neurochemistry, vol. 99, no. 3, pp. 868-880, 2006.
58. M.-L. B. Selenica, J. A. Alvarez, K. R. Nash et al., "Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain," Journal of Neuroinflammation, vol. 10, article 86, 2013.
59. K. J. Whitehead, C. G. S. Smith, S. A. Delaney et al., "Dynamic regulation of spinal pro-inflammatory cytokine release in the rat in vivo following peripheral nerve injury," Brain, Behavior, and Immunity, vol. 24, no. 4, pp. 569-576, 2010.
60. K. Miyoshi, K. Obata, T. Kondo, H. Okamura, and K. Noguchi, "Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury," Journal of Neuroscience, vol. 28, no. 48, pp. 12775-12787, 2008.
61. M. Prinz and U.-K. Hanisch, "Murine microglial cells produce and respond to interleukin-18," Journal of Neurochemistry, vol. 72, no. 5, pp. 2215-2218, 1999.
62. W. A. Verri Jr., T. M. Cunha, C. A. Parada et al., "Antigeninduced inflammatory mechanical hypernociception in mice is mediated by IL-18," Brain, Behavior, and Immunity, vol. 21, no. 5, pp. 535-543, 2007.
63. K. Suk, S. Yeou Kim, and H. Kim, "Regulation of IL-18 production by IFNγ and PGE2 in mouse microglial cells: involvement of NF-kB pathway in the regulatory processes," Immunology Letters, vol. 77, no. 2, pp. 79-85, 2001.
64. C. Juliana, T. Fernandes-Alnemri, J. Wu et al., "Antiinflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome," The Journal of Biological Chemistry, vol. 285, no. 13, pp. 9792-9802, 2010.
65. S. J. L. Flatters, A. J. Fox, and A. H. Dickenson, "Spinal interleukin-6 (IL-6) inhibits nociceptive transmission following neuropathy," Brain Research, vol. 984, no. 1-2, pp. 54-62, 2003.
66. S. Rose-John, "Il-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6," International Journal of Biological Sciences, vol. 8, no.9,pp. 1237-1247, 2012.
67. J. Scheller, A. Chalaris, D. Schmidt-Arras, and S. Rose-John, "The pro- and anti-inflammatory properties of the cytokine interleukin-6," Biochimica et Biophysica Acta, vol. 1813,no. 5, pp. 878-888, 2011.
68. D. L. Gruol and T. E. Nelson, "Physiological and pathological roles of interleukin-6 in the central nervous system," Molecular Neurobiology, vol. 15, no. 3, pp. 307-339, 1997.
69. A. I. Kaplin, D. M. Deshpande, E. Scott et al., "IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis," Journal of Clinical Investigation, vol. 115, no. 10, pp. 2731-2741, 2005.
70. R. Orihuela, C. A. McPherson, and G. J. Harry, "Microglial M1/M2 polarization and metabolic states," British Journal of Pharmacology, 2015.
71. J. A. DeLeo, R. W. Colburn, M. Nichols, and A. Malhotra, "Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model," Journal of Interferon and Cytokine Research, vol. 16, no. 9, pp. 695-700, 1996.
72. H.-L. Lee, K.-M. Lee, S.-J. Son, S.-H. Hwang, and H.-J. Cho, "Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model," NeuroReport, vol. 15, no. 18, pp. 2807-2811, 2004.
73. S. A. Kanaan, S. Poole, N. E. Saadé, S. Jabbur, and B. Safieh-Garabedian, "Interleukin-10 reduces the endotoxin-induced hyperalgesia in mice," Journal of Neuroimmunology, vol. 86, no. 2, pp. 142-150, 1998.
74. S. Poole, F. Q. Cunha, S. Selkirk, B. B. Lorenzetti, and S. H. Ferreira, "Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10," British Journal of Pharmacology, vol. 115, no. 4, pp. 684-688, 1995.
75. H. Tu, T. Juelich, E. M. Smith, S. K. Tyring, P. L. Rady, and T. K. Hughes Jr., "Evidence for endogenous interleukin-10 during nociception," Journal of Neuroimmunology, vol. 139, no. 1-2, pp. 145-149, 2003.
76. A. Pisanu, D. Lecca, G. Mulas et al., "Dynamic changes in proand anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease," Neurobiology of Disease, vol. 71, pp. 280-291, 2014.
77. Y. Kawasaki, Z.-Z. Xu, X. Wang et al., "Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain," Nature Medicine, vol. 14, no. 3, pp. 331-336, 2008.
78. J. R. Parkitna, M. Korostynski, D. Kaminska-Chowaniec et al., "Comparison of gene expression profiles in neuropathic and inflammatory pain," Journal of Physiology and Pharmacology, vol. 57, no. 3, pp. 401-414, 2006.
79. S. Lacraz, L. P. Nicod, R. Chicheportiche, H. G. Welgus, and J.-M. Dayer, "IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes," The Journal of Clinical Investigation, vol. 96, no. 5, pp. 2304-2310, 1995.
80. J. Wu, S. Yoo, D. Wilcock et al., "Interaction of NG2+ glial progenitors andmicroglia/macrophages from the injured spinal cord," Glia, vol. 58, no. 4, pp. 410-422, 2010.
81. R. E. von Leden, S. J. Cooney, T. M. Ferrara et al., "808 nmwavelength light induces a dose-dependent alteration in microglial polarization and resultant microglial induced neurite growth," Lasers in Surgery andMedicine, vol. 45, no. 4, pp. 253-263, 2013.
82. A. A. Beg and D. Baltimore, "An essential role for NF-κB in preventing TNF-γ-induced cell death," Science, vol. 274, no. 5288, pp. 782-784, 1996.
83. C.-Y. Wang, M. W. Mayo, and A. S. Baldwin Jr., "TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB," Science, vol. 274, no. 5288, pp. 784-787, 1996.
84. W. van den Berghe, S. Plaisance, E. Boone et al., "p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor," The Journal of Biological Chemistry, vol. 273, no. 6, pp. 3285-3290, 1998.
85. E. Niederberger and G. Geisslinger, "The IKK-NF-kappaB pathway: a source for novel molecular drug targets in pain therapy?," The FASEB Journal, vol. 22, no. 10, pp. 3432-3442, 2008.
86. H. Katsura, K. Obata, T. Mizushima et al., "Activation of Srcfamily kinases in spinal microglia contributes to mechanical hypersensitivity after nerve injury," Journal of Neuroscience, vol. 26, no. 34, pp. 8680-8690, 2006.
87. C. I. Svensson, M. Schäfers, T. L. Jones, H. Powell, and L. S. Sorkin, "Spinal blockade of TNF blocks spinal nerve ligationinduced increases in spinal P-p38," Neuroscience Letters, vol. 379, no. 3, pp. 209-213, 2005.
88. M. Han, R.-Y. Huang, Y.-M. Du, Z.-Q. Zhao, and Y.-Q. Zhang, "Early intervention of ERK activation in the spinal cord can block initiation of peripheral nerve injury-induced neuropathic pain in rats," Sheng Li Xue Bao, vol. 63, no. 2, pp. 106-114, 2011.
89. Y. Cui, Y. Chen, J.-L. Zhi, R.-X. Guo, J.-Q. Feng, and P.-X. Chen, "Activation of p38 mitogen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance," Brain Research, vol. 1069, no. 1, pp. 235-243, 2006.
90. Z.-Y. Zhuang, P. Gerner, C. J. Woolf, and R.-R. Ji, "ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes tomechanical allodynia in this neuropathic pain model," Pain, vol. 114, no. 1-2, pp. 149-159, 2005.
91. A. Jarnicki, T. Putoczki, and M. Ernst, "Stat3: linking inflammation to epithelial cancer - more than a 'gut' feeling?," Cell Division, vol. 5, article 14, 2010.
92. H. Yasukawa, M. Ohishi, H. Mori et al., "IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages," Nature Immunology, vol. 4, no. 6, pp. 551-556, 2003.
93. X. Chen, W. Liu, J. Wang, X. Wang, and Z. Yu, "STAT1 and STAT3 mediate thrombin-induced expression of TIMP-1 in human glomerular mesangial cells," Kidney International, vol. 61, no. 4, pp. 1377-1382, 2002.
94. R. Lai,G. Z. Rassidakis, L. J. Medeiros et al., "Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma," The American Journal of Pathology, vol. 164, no. 6, pp. 2251-2258, 2004.
95. V. Kaushal, P. D. Koeberle, Y. Wang, and L. C. Schlichter, "The Ca2+-activated K+ channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration," The Journal of Neuroscience, vol. 27, no. 1, pp. 234-244, 2007.
96. K. A. Kigerl, J. C. Gensel, D. P. Ankeny, J. K. Alexander, D. J. Donnelly, and P. G. Popovich, "Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injuredmouse spinal cord," The Journal of Neuroscience, vol. 29, no. 43, pp. 13435-13444, 2009.
97. F. Ferrini and Y. de Koninck, "Microglia control neuronal network excitability via BDNF signalling," Neural Plasticity, vol. 2013, Article ID 429815, 11 pages, 2013.